MoneyWorks4Me

Gufic Biosciences - Quaterly Results

10 Feb 2023 Evaluate
The quarter ended December 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1774.73 millions.Net profit declined -3.32% to Rs. 203.36 millions from Rs. 210.34 millions.Operating Profit reported a sharp decline to 341.49 millions from 342.49 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1774.73 1720.65 3.14 5175.84 6169.62 -16.11 7791.56 4876.99 59.76
Other Income 7.57 15.30 -50.52 19.50 30.63 -36.34 31.04 37.33 -16.85
PBIDT 341.49 342.49 -0.29 1011.34 1172.59 -13.75 1488.20 876.53 69.78
Interest 21.60 10.32 109.30 46.74 37.90 23.32 48.47 136.33 -64.45
PBDT 319.89 332.17 -3.70 964.60 1134.69 -14.99 1439.73 740.20 94.51
Depreciation 47.41 44.84 5.73 136.70 128.07 6.74 171.34 163.08 5.06
PBT 272.48 287.33 -5.17 827.90 1006.62 -17.75 1268.39 577.12 119.78
TAX 69.12 76.99 -10.22 211.90 250.86 -15.53 309.98 134.80 129.96
Deferred Tax -0.38 4.29 -108.86 -8.20 -4.14 98.07 -11.52 20.11 -157.28
PAT 203.36 210.34 -3.32 616.00 755.76 -18.49 958.41 442.32 116.68
Equity 96.95 96.95 0.00 96.95 96.95 0.00 96.94 96.94 0.00
PBIDTM(%) 19.24 19.90 -3.33 19.54 19.01 2.81 19.10 17.97 6.27
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..